Inhibitors of PKA and Related Protein Kinases

作者: M. Gaßel , C. Breitenlechner , S. Herrero , R. Engh , D. Bossemeyer

DOI: 10.1007/3-540-26670-4_5

关键词:

摘要: The AGC group of protein kinases comprises a number pharmacologically important members—targets for small molecule inhibitors therapeutic value. Crystal structure data assist in the design new or improved inhibitory molecules. Protein kinase A (PKA), one longest and best-known members group, has been cocrystallized with many from highly diverse chemical groups, including isoquinoline derivatives, staurosporine bisindolylmaleimide cognates, balanol pyridine thus providing structural information about binding modes, selectivity cross selectivity. creation ‘ersatz’ by mutating inhibitor site PKA to resemble other fellow cocrystallization these ersatz molecules as well cocrystal structures like 3-phosphoinositide-dependent 1 (PDK1) derivatives helps identification exploration factors governing

参考文章(127)
Richard A Engh, Dirk Bossemeyer, The protein kinase activity modulation sites: Advances in Enzyme Regulation. ,vol. 41, pp. 121- 149 ,(2001) , 10.1016/S0065-2571(00)00010-8
J. Hofmann, Modulation of protein kinase C in antitumor treatment Reviews of Physiology Biochemistry and Pharmacology. ,vol. 142, pp. 1- 96 ,(2001) , 10.1007/BFB0117491
Dylan T Jones, Atul B Mehta, H Grant Prentice, Kanagasabai Ganeshaguru, A Victor Hoffbrand, Katalin Csermak, Ranmohan G Wickremasinghe, Andres E Virchis, Kate Champain, Steve M Hart, Anthony Man, Mathew Gordon, Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. Haematologica. ,vol. 87, pp. 167- 176 ,(2002)
Hiroaki Shimokawa, Hiroyuki Iinuma, Hiroshi Kishida, Kazuzo Katoh, Mitsuyoshi Nakashima, Antianginal effect of fasudit, a Rho-kinase inhibitor, in patients with stable effort angina : a multicenter study Japanese Circulation Journal-english Edition. ,vol. 66, pp. 203- ,(2002)
Peter Campochiaro, Stephan Bodis, Doriano Fabbro, Terence O'Reilly, Martin Pruschy, Jeanette Wood, Stephan Ruetz, Thomas Meyer, Katalin Csermak, Anthony Man, PKC412--a protein kinase inhibitor with a broad therapeutic potential. Anti-cancer Drug Design. ,vol. 15, pp. 17- 28 ,(2000)
A. Kishimoto, Y. Takai, Y. Nishizuka, Activation of glycogen phosphorylase kinase by a calcium-activated, cyclic nucleotide-independent protein kinase system. Journal of Biological Chemistry. ,vol. 252, pp. 7449- 7452 ,(1977) , 10.1016/S0021-9258(17)40987-2
T. Matsui, M. Amano, T. Yamamoto, K. Chihara, M. Nakafuku, M. Ito, T. Nakano, K. Okawa, A. Iwamatsu, K. Kaibuchi, Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho The EMBO Journal. ,vol. 15, pp. 2208- 2216 ,(1996) , 10.1002/J.1460-2075.1996.TB00574.X
Flavio Meggio, Arianna Donella Deana, Maria Ruzzene, Anna M. Brunati, Luca Cesaro, Barbara Guerra, Thomas Meyer, Helmut Mett, Doriano Fabbro, Pascal Furet, Grazyna Dobrowolska, Lorenzo A. Pinna, Different susceptibility of protein kinases to staurosporine inhibition Kinetic studies and molecular bases for the resistance of protein kinase CK2 FEBS Journal. ,vol. 234, pp. 317- 322 ,(1995) , 10.1111/J.1432-1033.1995.317_C.X